Loading...

Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation

The p38 mitogen activated protein kinase pathway (MAPK) is known to promote cell survival, endocrine therapy resistance and hormone independent breast cancer cell proliferation. Therefore, we utilized the novel p38 inhibitor RWJ67657 to investigate the relevance of targeting this pathway in the ER(+...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Antoon, James W., Bratton, Melyssa R., Guillot, Lori M., Wadsworth, Scott, Salvo, Virgilio A., Burow, Matthew E.
Format: Artigo
Sprog:Inglês
Udgivet: Landes Bioscience 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461809/
https://ncbi.nlm.nih.gov/pubmed/22825349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.20992
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!